Laura Pitlik - 11 Apr 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Marketing Officer
Signature
Laura Pitlik, by Attorney-in-Fact, Cesare Suardi
Issuer symbol
RKDA
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
4
Filing time
13 Apr 2022, 16:01:34 UTC
Previous filing
13 Jul 2021
Next filing
18 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +31,000 +32% $0.000000 129,000 11 Apr 2022 Common Stock 31,000 $1.27 Direct F1
transaction RKDA Stock Option (right to buy) Award $0 +23,000 +22% $0.000000 129,000 11 Apr 2022 Common Stock 23,000 $1.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.
F2 The Option vests in two equal installments occurring on the first, and second anniversary of the date of grant, subject to the Participant's continued service.

Remarks:

None